ABBV

AbbVie

Halal Rating :
Comfortable
Last Price $171.30 Last updated:
Market Cap $303.17b
7D Change -3.08%
1 Year Change 3.57%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 25, 2024

AbbVie Inc. is a global biopharmaceutical company engaged in the discovery, development, manufacture, and sale of a broad range of innovative pharmaceutical products. The company was formed in 2013 as a spin-off from Abbott Laboratories. AbbVie's portfolio includes treatments for serious conditions including immunology, oncology, virology, neuroscience, and women's health.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $14.46b $10.63b - - 0.00% 0.00%
June 30, 2024 $14.46b $10.46b - - 0.00% 0.00%
March 31, 2024 $12.31b $9.51b - - 0.00% 0.00%

Company Impact

Help us evaluate AbbVie's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates